首页 工具
登录
购物车

搜索结果

Search Results for " benign "

34

抑制剂 & 化合物

6

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T0488 Finasteride

非那雄胺,MK-906

Reductase Endocrinology/Hormones; Metabolism
Finasteride (MK-906) 是 5α-还原酶的竞争性抑制剂,对 II 型 5α-还原酶的IC50为 4.2 nM,对 II 型 5α-还原酶的亲和力是 I 型酶的 100 倍。它可用于研究前列腺增生和雄激素性脱发。
T0197 Terazosin hydrochloride

盐酸特拉唑嗪,Terazosin HCl,Terazosine,Blavin,Hytrin,Zayasel,Fosfomic

Adrenergic Receptor GPCR/G Protein; Neuroscience
Terazosin hydrochloride (Hytrin) 是一种竞争性和口服活性的 α1-肾上腺素受体拮抗剂,是一种喹唑啉衍生物。它通过舒张血管和打开膀胱来起作用。它可用于良性前列腺增生和高血压的研究。
T1504 Silodosin

西洛多辛,KAD 3213,KMD 3213

Adrenergic Receptor GPCR/G Protein; Neuroscience
Silodosin (KAD 3213) 是有选择性的、强效的、口服活性的 α1A-adrenergic receptor 阻滞剂,是一种有效且耐受性良好的试剂,可用于研究 LUTS/BPH。它对 α1A-AR 表现出高度的亲和力,是 α1B-AR 和 α1D-AR 亲和力的 162 和 50 倍。
T6461 Dapoxetine hydrochloride

LY-210448,LY-210448 hydrochloride,Dapoxetine HCl,盐酸达泊西汀,Priligy

5-HT Receptor; Serotonin Transporter GPCR/G Protein; Neuroscience
Dapoxetine hydrochloride (LY-210448 hydrochloride) 是一种具有口服活性的、选择性的血清素再摄取 (serotonin reuptake) 抑制剂 (SSRI),可用于研究早泄 (PE) 。
T6701 Terazosin hydrochloride dihydrate

Flotrin dihydrate,Terazosin HCl Dihydrate,Dysalfa dihydrate,Heitrin dihydrate,盐酸特拉唑嗪(二水合物)

Adrenergic Receptor GPCR/G Protein; Neuroscience
Terazosin hydrochloride dihydrate (Heitrin dihydrate) 是一种竞争性和口服活性的 α1-肾上腺素受体(α1-adrenoceptor) 拮抗剂,是一种喹唑啉衍生物,通过舒张血管和打开膀胱的方式起作用。它可用于研究良性前列腺增生 (BPH) 和高血压。
T0039 Dapoxetine

达波西汀,Dapoxetina,Dapoxetinum

Others; 5-HT Receptor GPCR/G Protein; Neuroscience; Others
Dapoxetine (Dapoxetina) 是一种选择性5-羟色胺再摄取抑制剂,用于治疗早泄。
T13703 Gestonorone Capronate

Prostaglandin Receptor GPCR/G Protein; Immunology/Inflammation
Gestonorone Capronate 是一种孕激素,在良性前列腺肥大和子宫内膜癌领域有研究价值。
T14843 Bifluranol

BX341

Androgen Receptor Endocrinology/Hormones
Bifluranol (BX341) 具有抗雄激素活性,在体内实验中显示出显著的抗前列腺活性,可用于治疗良性前列腺增生 (BPH)。
T22316 Doxazosin

UK 33274,多沙唑嗪

Adrenergic Receptor GPCR/G Protein; Neuroscience
Doxazosin (UK 33274) 是选择性的拮抗突触后的α1肾上腺素受体。
T27798 Lapisteride

CS891B,CS-891,CS-891B,CS891

Others Others
Lapisteride (CS-891) 一种类固醇5α-还原酶抑制剂,可用于治疗良性前列腺增生(BPH)和雄激素性脱发,可有效预防或治疗AGA 。
T28922 Taprizosin

Taprizosin Mesylate,UK-338003,UK-338,003,UK338003,UK 338003

Adrenergic Receptor GPCR/G Protein; Neuroscience
Taprizosin(UK-338003)是一种具有选择性和口服活性的 α1-肾上腺素受体 (α1-adrenoceptor) 拮抗剂,可用于舒张血管,用于治疗良性前列腺增生症。
T15688 L-771688

SNAP 6383

Adrenergic Receptor GPCR/G Protein; Neuroscience
L-771688(SNAP 6383) 是一种新型有效和选择性的 α1A-肾上腺素受体拮抗剂, Ki 值为 0.43±0.02 nM。L-771688 KE 用于治疗良性前列腺增生。
T1499 Dutasteride

GG 745,Avodart,度他雄胺,GI 198745

Apoptosis; Reductase Apoptosis; Endocrinology/Hormones; Metabolism
Dutasteride (GI 198745) 是一种 5α 还原酶同工酶抑制剂,还可能因其结构域 DHT 相似对雄激素受体产生脱靶效应。
T83965 Tamsolusin Hydrochloride

YM 12617,LY-253352

Adrenergic Receptor GPCR/G Protein; Neuroscience
Tamsolusin Hydrochloride (YM 12617) 是一种高选择性α-1A肾上腺素受体拮抗剂,可用于治疗良性前列腺肥大。
T0091 Alfuzosin hydrochloride

SL 77499-10,Alfuzosin HCl,盐酸阿夫唑嗪

Adrenergic Receptor GPCR/G Protein; Neuroscience
Alfuzosin hydrochloride (Alfuzosin HCl) 是一种 α1 肾上腺素受体拮抗剂,可用于良性前列腺增生(BPH)的研究。
T35182 Xinidamine

BRN 0891979,Xinidaminum,Xinidamino

Xinidamine (BRN 0891979) 具有抗肿瘤活性,可用于研究良性前列腺增生、黄斑变性和前列腺上皮内瘤 。Xinidamine 对PWR-1E 细胞的增殖具有抑制作用,IC50为4μM。
T11286 Fiduxosin

A 185980.1,ABT 980

Adrenergic Receptor GPCR/G Protein; Neuroscience
Fiduxosin 是一种具有选择性和有效性的 α1-adrenoceptor 拮抗剂,对 α1a-adrenoceptor,α1b-adrenoceptor 和 α1d-adrenoceptor 有抑制作用,Ki 值分别为 0.160 nM,24.9 nM 和 0.920 nM。Fiduxosin 可用于治疗良性前列腺增生。
T0210L Tamsulosin

LY253351 free base,HSDB7744,(R)-(-)-YM12617 free base,Harnal-D,Flowmax,HSDB 7744,HSDB-7744

Adrenergic Receptor GPCR/G Protein; Neuroscience
Tamsulosin ((R)-(-)-YM12617 free base) 是一种肾上腺素能受体α 1A 拮抗剂,用于良性前列腺增生(BPH)的治疗。Tansulosin 用于治疗排尿困难,这是前列腺肥大的一种常见症状。Tansulosin 和其他被称为α受体阻滞剂的药物通过放松膀胱颈部肌肉和前列腺本身的肌肉纤维来发挥作用,使其更容易排尿。
T22232 Alfuzosin

Alfuzosin 是选择性和竞争性的α1肾上腺素受体拮抗剂,可用于良性前列腺增生(BPH)的研究。
T28956 TF-505

FR-146687,FK-687,TF 505,FK687

TF-505, a steroid 5α-reductase inhibitor, is used potentially for the treatment of benign prostatic hyperplasia.
T33069 Lysinenorleucine

Lys-nle

Lysinenorleucine s a Lysine and hydroxylysine derivatives that can be used for the treatment of malignant and benign tumors.
T70396 Fexapotide triflutate

Fexapotide triflutate is a caspase and TNF signaling pathway activator used to treat benign prostatic hyperplasia (BPH).
T20024 Tadalafil, (6R ,12aS)-

Tadalafil (6R ,12aS)- Lilly,Tadalafil specified impurity A,(-)-Tadalafil (6R ,12aS) diastereomer

Tadalafil is a carboline derivative and Phosphodiesterase 5 Inhibitor. It is used primarily to treat Erectile dysfunction, Benign Prostatic Hyperplasia, and Primary Pulmonary Hypertension.
T32029 GYKI-16084

GYKI 16084

GYKI-16084 is a postsynaptic alpha2 receptor blocker with potential efficacy in the treatment of benign prostatic hyperplasia.
T24378 L-771688 dihydrochloride

L 771688 dihydrochloride

L-771688 is an α1A-adrenoceptor antagonist potentially for the treatment of benign prostatic hyperplasia.
T3290L Pikamilone Sodium

GABA-NG,Nicotinoyl-GABA sodium salt,GABA NG,GABANG,Pikamilone Na

Pikamilone Sodium is a prodrug of GABA used for therapy of neurogenic bladder in spinal and benign prostatic hyperplasia.
T69927 Fiduxosin hydrochloride

Fiduxosin hydrochloride is an alpha 1a-adrenoceptor antagonist that may be useful in the treatment of Benign Prostatic Hyperplasia.
T61729 Terazosin

Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].
T28245 ONO-0300302

ONO 0300302

ONO-0300302 is a slow tight binding LPA1 antagonist (IC50: 0.16 nM) used to treat Benign Prostatic Hyperplasia. ONO-0300302 inhibits significantly an LPA-induced increase of intraurethral pressure (IUP) in rat (3 mg/kg, p.o.) and dog (1 mg/kg, p.o.) over
T36859 C16 Globotriaosylceramide (d18:1/16:0)

C16 Globotriaosylceramide (d18:1/16:0)

C16 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from C16 lactosylceramide . C16 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes. It accumulates in endothelial cells, pericytes, vascular smooth muscle cells, renal epithelial cells, dorsal ganglia neuronal cells, and myocardial cells in patients with Fabry disease. C16 globotriaosylceramide is also upregulated in plasma of patien...
T76275 Fexapotide

Fexapotide (NX-1207 free acid) 在细胞水平上通过选择性诱导细胞凋亡,降低前列腺体积。它主要用于研究下尿路症状(LUTS)与良性前列腺增生(BPH)。
T62841 Tinlorafenib

Tinlorafenib (PF-07284890) (compound 10) 是一种口服具有活力的、具有中枢神经系统 (CNS) 渗透性的 BRAF kinase 抑制剂,能够作用于 BRAFV600E (IC50: 4.25 nM) 和 V600K (IC50: 2.7 nM)。Tinlorafenib 能够用于 BRAF 相关的中枢神经系统恶性和良性肿瘤以及颅外恶性肿瘤的研究。
T21668 Finasteride acetate

Finasteride (MK-906) acetate 是一种高效的5α-还原酶 (5α-reductase) 竞争性抑制剂,其对 II 型 5α-还原酶的IC50值仅为 4.2 nM,其对该型酶的亲和力是对 I 型酶亲和力的约100倍。因此,Finasteride acetate 主要在良性前列腺增生症 (BPH) 和雄激素性脱发研究领域中应用。
T60935 H-Tyr-Phe-OH

H-Tyr-Phe-OH (L-Tyrosyl-L-phenylalanine) 可用作区分良性甲状腺结节和甲状腺癌的生物标志物。H-Tyr-Phe-OH 是一种口服活性的血管紧张素转换酶抑制剂,在50 μM 时抑制率为 48%。H-Tyr-Phe-OH 具有黄嘌呤氧化酶抑制活性 (降低尿酸) ,可调节中性粒细胞样细胞中 IL-8 的产生。

化合物

Finasteride
Cat.No: T0488
Synonym: 非那雄胺,MK-906
Target: Reductase
Terazosin hydrochloride
Cat.No: T0197
Synonym: 盐酸特拉唑嗪,Terazosin HCl,Terazosine,Blavin,Hytrin,Zayasel,Fosfomic
Target: Adrenergic Receptor
Silodosin
Cat.No: T1504
Synonym: 西洛多辛,KAD 3213,KMD 3213
Target: Adrenergic Receptor
Dapoxetine hydrochloride
Cat.No: T6461
Synonym: LY-210448,LY-210448 hydrochloride,Dapoxetine HCl,盐酸达泊西汀,Priligy
Target: 5-HT Receptor, Serotonin Transporter
Terazosin hydrochloride dihydrate
Cat.No: T6701
Synonym: Flotrin dihydrate,Terazosin HCl Dihydrate,Dysalfa dihydrate,Heitrin dihydrate,盐酸特拉唑嗪(二水合物)
Target: Adrenergic Receptor
Dapoxetine
Cat.No: T0039
Synonym: 达波西汀,Dapoxetina,Dapoxetinum
Target: Others, 5-HT Receptor
Gestonorone Capronate
Cat.No: T13703
Synonym:
Target: Prostaglandin Receptor
Bifluranol
Cat.No: T14843
Synonym: BX341
Target: Androgen Receptor
Doxazosin
Cat.No: T22316
Synonym: UK 33274,多沙唑嗪
Target: Adrenergic Receptor
Lapisteride
Cat.No: T27798
Synonym: CS891B,CS-891,CS-891B,CS891
Target: Others
Taprizosin
Cat.No: T28922
Synonym: Taprizosin Mesylate,UK-338003,UK-338,003,UK338003,UK 338003
Target: Adrenergic Receptor
L-771688
Cat.No: T15688
Synonym: SNAP 6383
Target: Adrenergic Receptor
Dutasteride
Cat.No: T1499
Synonym: GG 745,Avodart,度他雄胺,GI 198745
Target: Apoptosis, Reductase
Tamsolusin Hydrochloride
Cat.No: T83965
Synonym: YM 12617,LY-253352
Target: Adrenergic Receptor
Alfuzosin hydrochloride
Cat.No: T0091
Synonym: SL 77499-10,Alfuzosin HCl,盐酸阿夫唑嗪
Target: Adrenergic Receptor
Xinidamine
Cat.No: T35182
Synonym: BRN 0891979,Xinidaminum,Xinidamino
Target:
Fiduxosin
Cat.No: T11286
Synonym: A 185980.1,ABT 980
Target: Adrenergic Receptor
Tamsulosin
Cat.No: T0210L
Synonym: LY253351 free base,HSDB7744,(R)-(-)-YM12617 free base,Harnal-D,Flowmax,HSDB 7744,HSDB-7744
Target: Adrenergic Receptor
Alfuzosin
Cat.No: T22232
Synonym:
Target:
TF-505
Cat.No: T28956
Synonym: FR-146687,FK-687,TF 505,FK687
Target:
Lysinenorleucine
Cat.No: T33069
Synonym: Lys-nle
Target:
Fexapotide triflutate
Cat.No: T70396
Synonym:
Target:
Tadalafil, (6R ,12aS)-
Cat.No: T20024
Synonym: Tadalafil (6R ,12aS)- Lilly,Tadalafil specified impurity A,(-)-Tadalafil (6R ,12aS) diastereomer
Target:
GYKI-16084
Cat.No: T32029
Synonym: GYKI 16084
Target:
L-771688 dihydrochloride
Cat.No: T24378
Synonym: L 771688 dihydrochloride
Target:
Pikamilone Sodium
Cat.No: T3290L
Synonym: GABA-NG,Nicotinoyl-GABA sodium salt,GABA NG,GABANG,Pikamilone Na
Target:
Fiduxosin hydrochloride
Cat.No: T69927
Synonym:
Target:
Terazosin
Cat.No: T61729
Synonym:
Target:
ONO-0300302
Cat.No: T28245
Synonym: ONO 0300302
Target:
C16 Globotriaosylceramide (d18:1/16:0)
Cat.No: T36859
Synonym: C16 Globotriaosylceramide (d18:1/16:0)
Target:
Fexapotide
Cat.No: T76275
Synonym:
Target:
Tinlorafenib
Cat.No: T62841
Synonym:
Target:
Finasteride acetate
Cat.No: T21668
Synonym:
Target:
H-Tyr-Phe-OH
Cat.No: T60935
Synonym:
Target:
Cat. No. Product Name Target Signaling Pathways
TN3651 Cichoriin

Others Others
Cichoriin 对SARS-CoV-2有明显活性,是治疗重症COVID-19的潜在候选物质。
T19687 Phenylethyl isothiocyanate

JC 5411,2-苯基乙基异硫代氰酸酯,JC5411,JC-5411

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
Phenylethyl isothiocyanate (JC5411) 是一种 HDAC 抑制剂。它有可能用于治疗良性前列腺肥大。
TN5031 Sitostenone

豆甾-4-烯-3-酮

Others Others
Sitostenone 具有抗氧化活性。 Stigmasta-4-en-3-one(Sitostenone)可用于治疗雄激素依赖性疾病,尤其是治疗良性前列腺增生。
T39836 Monoethyl phthalate

Monoethyl phthalate is a metabolite of diethyl phthalate, serving as a urinary biomarker for phthalate exposure, and indicating potential risks of thyroid cancer and benign nodules.
TN1061 Ganoderol B

Androgen Receptor Endocrinology/Hormones
Ganoderol B is a potent β ±-glucosidase and angiotensin-converting enzyme inhibitor, with an IC(50) of β ±-glucosidase is 119.8 uM. It may be useful in prostate cancer and benign prostatic hyperplasia (BPH) therapy through suppressing the function of andr
TN4164 Grandifloroside

TNF Apoptosis
Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory ag

天然产物

Cichoriin
Cat.No: TN3651
Synonym:
Target: Others
Phenylethyl isothiocyanate
Cat.No: T19687
Synonym: JC 5411,2-苯基乙基异硫代氰酸酯,JC5411,JC-5411
Target: HDAC
Sitostenone
Cat.No: TN5031
Synonym: 豆甾-4-烯-3-酮
Target: Others
Monoethyl phthalate
Cat.No: T39836
Synonym:
Target:
Ganoderol B
Cat.No: TN1061
Synonym:
Target: Androgen Receptor
Grandifloroside
Cat.No: TN4164
Synonym:
Target: TNF
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼